CSPC Pharmaceutical Group Limited - Laporan Laba Rugi (TTM)

CSPC Pharmaceutical Group Limited
HK ˙ SEHK ˙ HK1093012172
HK$ 11.19 ↑0.36 (3.32%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi CSPC Pharmaceutical Group Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 24,558 24,942 25,551 26,175 26,369 27,867 29,007 29,655 30,721 30,937 31,116 31,407 31,306 31,450 32,380 31,654 30,271 29,009 27,041 25,998
Change (%) 1.57 2.44 2.44 0.74 5.68 4.09 2.23 3.59 0.70 0.58 0.94 -0.32 0.46 2.96 -2.24 -4.37 -4.17 -6.78 -3.86
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 6,078 6,257 6,210 6,402 6,484 6,732 7,245 7,706 8,159 8,680 9,152 9,252 9,340 9,273 9,226 9,060 8,901 8,711 8,533 8,644
Change (%) 2.94 -0.74 3.09 1.27 3.82 7.63 6.35 5.88 6.40 5.43 1.09 0.96 -0.72 -0.51 -1.80 -1.76 -2.14 -2.04 1.30
% of Revenue 24.75 25.09 24.31 24.46 24.59 24.16 24.98 25.98 26.56 28.06 29.41 29.46 29.83 29.49 28.49 28.62 29.41 30.03 31.55 33.25
Gross Operating Profit 18,479 18,685 19,340 19,773 19,885 21,135 21,762 21,949 22,562 22,256 21,964 22,156 21,966 22,177 23,154 22,594 21,370 20,299 18,508 17,354
Change (%) 1.12 3.50 2.24 0.57 6.29 2.97 0.86 2.79 -1.35 -1.31 0.87 -0.85 0.96 4.40 -2.42 -5.42 -5.01 -8.82 -6.24
% of Revenue 75.25 74.91 75.69 75.54 75.41 75.84 75.02 74.02 73.44 71.94 70.59 70.54 70.17 70.51 71.51 71.38 70.59 69.97 68.45 66.75
SG&A 10,522 10,323 10,332 10,703 10,747 11,453 11,700 11,611 11,915 11,510 11,177 10,973 10,410 10,330 10,872 10,303 9,948 9,742 8,338 7,783
Change (%) -1.88 0.08 3.60 0.41 6.57 2.16 -0.76 2.62 -3.40 -2.90 -1.82 -5.13 -0.77 5.24 -5.24 -3.44 -2.07 -14.41 -6.67
% of Revenue 42.84 41.39 40.44 40.89 40.76 41.10 40.34 39.15 38.79 37.21 35.92 34.94 33.25 32.85 33.58 32.55 32.86 33.58 30.84 29.93
R&D 2,765 2,890 3,013 3,050 3,132 3,433 3,643 3,704 3,845 3,987 4,093 4,406 4,744 4,830 4,992 5,069 5,032 5,191 5,324 5,331
Change (%) 4.51 4.26 1.24 2.67 9.61 6.12 1.67 3.81 3.69 2.66 7.66 7.68 1.82 3.35 1.54 -0.72 3.15 2.56 0.15
% of Revenue 11.26 11.59 11.79 11.65 11.88 12.32 12.56 12.49 12.51 12.89 13.15 14.03 15.15 15.36 15.42 16.01 16.62 17.89 19.69 20.51
OpEx 19,392 19,470 19,555 20,156 20,380 21,618 22,588 23,020 23,918 24,177 24,422 24,631 24,495 24,434 25,090 24,432 23,881 23,643 22,195 21,758
Change (%) 0.40 0.44 3.07 1.11 6.07 4.49 1.91 3.90 1.08 1.01 0.86 -0.55 -0.25 2.68 -2.62 -2.25 -1.00 -6.13 -1.97
% of Revenue 78.97 78.06 76.53 77.01 77.29 77.57 77.87 77.63 77.86 78.15 78.49 78.42 78.24 77.69 77.49 77.18 78.89 81.50 82.08 83.69
Operating Income 5,165 5,472 5,995 6,019 5,989 6,249 6,419 6,634 6,802 6,760 6,695 6,776 6,812 7,016 7,290 7,222 6,390 5,366 4,847 4,241
Change (%) 5.94 9.56 0.39 -0.50 4.35 2.71 3.36 2.53 -0.63 -0.96 1.22 0.53 3.00 3.90 -0.92 -11.53 -16.02 -9.68 -12.50
% of Revenue 21.03 21.94 23.47 22.99 22.71 22.43 22.13 22.37 22.14 21.85 21.51 21.58 21.76 22.31 22.51 22.82 21.11 18.50 17.92 16.31
Interest Expense -10 -12 -13 -11 -11 -8 -8 -13 -16 -25 -26 -26 -27 -26 -28 -37 -42 -44 -44 -43
Change (%) 18.53 5.36 -11.03 -7.61 -27.66 0.33 63.90 28.69 53.48 6.31 -2.16 3.39 -3.26 6.47 34.73 13.89 3.22 1.45 -2.16
% of Revenue -0.04 -0.05 -0.05 -0.04 -0.04 -0.03 -0.03 -0.04 -0.05 -0.08 -0.09 -0.08 -0.09 -0.08 -0.09 -0.12 -0.14 -0.15 -0.16 -0.17
Net Income 4,421 5,160 5,472 5,908 5,977 5,605 5,538 5,509 5,738 6,091 6,116 6,092 6,118 5,873 6,057 5,927 5,157 4,328 4,193 3,856
Change (%) 16.71 6.05 7.98 1.16 -6.22 -1.20 -0.53 4.16 6.16 0.40 -0.38 0.43 -4.00 3.13 -2.16 -12.99 -16.07 -3.12 -8.05
% of Revenue 18.00 20.69 21.42 22.57 22.67 20.11 19.09 18.58 18.68 19.69 19.65 19.40 19.54 18.68 18.71 18.72 17.04 14.92 15.51 14.83

Source: Capital IQ

Other Listings
MX:1093 N
US:CHJTF
DE:CVG € 1.25
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista